- In June 2021, Nuvo Group received the United States Food and Drug Administration approval for the expanded utility of its INVU, which is a prescription-initiated remote pregnancy monitoring platform for the addition of a new uterine activity module that enables remote monitoring of uterine activity
- In June 2020, Philips launched the Avalon CL Fetal and Maternal Pod and Patch in the United States to support fetal and maternal monitoring. This device allows the continuous, non-invasive monitoring of maternal heart rate, fetal heart rate, and uterine activity by placing the single-use, 48-hour, disposable electrode patch on the mother’s abdomen
